A marker for Stevens-Johnson syndrome ...: ethnicity matters.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Works matching IS 1470269X AND DT 2006 AND VI 6 AND IP 4
Results: 9
1
2
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
3
Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
4
Pharmacogenetic research and data protection – challenges and solutions.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 4, p. 225, doi. 10.1038/sj.tpj.6500372
- By:
- Publication type:
- Article
5
Haloperidol induces apoptosis via the σ2 receptor system and Bcl-XS.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
6
Overview of the pharmacogenetics of HIV therapy.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
7
Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use.
- Published in:
- 2006
- By:
- Publication type:
- Abstract
8
Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
9
In this Issue.
- Published in:
- Pharmacogenomics Journal, 2006, v. 6, n. 4, p. 221, doi. 10.1038/sj.tpj.6500408
- Publication type:
- Article